Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

//Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to receive approvals to sell its endocrine and lung cancer drugs in China by June next year, chief executive officer Christian Hogg said.The cancer drugs manufacturing and innovation unit of billionaire Li Ka-shing‘s conglomerate CK Hutchison, plans to triple the size of its marketing team over the next three years in anticipation of the green light, he added. That will take the…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2020-10-01T10:30:08+00:00 October 1st, 2020|Business|Comments Off on Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London